TY - JOUR AU - Bearak, J. AU - Popinchalk, A. AU - Alkema, L. AU - Sedgh, G. PY - 2018 DA - 2018// TI - Global, regional, and subregional trends in unintended pregnancy and its outcomes from 1990 to 2014: estimates from a Bayesian hierarchical model JO - Lancet Glob Health VL - 6 UR - https://doi.org/10.1016/S2214-109X(18)30029-9 DO - 10.1016/S2214-109X(18)30029-9 ID - Bearak2018 ER - TY - JOUR AU - Ganatra, B. AU - Gerdts, C. AU - Rossier, C. AU - Johnson, B. R. AU - Tunçalp, Ö. AU - Assifi, A. PY - 2017 DA - 2017// TI - Global, regional, and subregional classification of abortions by safety, 2010–14: estimates from a Bayesian hierarchical model JO - Lancet VL - 390 UR - https://doi.org/10.1016/S0140-6736(17)31794-4 DO - 10.1016/S0140-6736(17)31794-4 ID - Ganatra2017 ER - TY - JOUR AU - Jain, R. AU - Muralidhar, S. PY - 2011 DA - 2011// TI - Contraceptive methods: needs, options and utilization JO - J Obstet Gynaecol India VL - 61 UR - https://doi.org/10.1007/s13224-011-0107-7 DO - 10.1007/s13224-011-0107-7 ID - Jain2011 ER - TY - STD TI - IMPLANON™ Package Insert [Internet]. FDA. https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021529s011lbl.pdf. UR - https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021529s011lbl.pdf ID - ref4 ER - TY - JOUR AU - Maddox, D. D. AU - Rahman, Z. PY - 2008 DA - 2008// TI - Etonogestrel (Implanon), another treatment option for contraception JO - Pharm Ther VL - 33 ID - Maddox2008 ER - TY - STD TI - Addendum to Clinical Guideline 30, Long-acting reversible contraception. This replaces Chapter 7: Progestogen-only subdermal implants (POSDIs) in clinical guideline 30—Google Search [Internet]. [cited 2018 Nov 6]. https://www.google.co.in/search?q=Addendum+to+Clinical+Guideline+30%2C+Long-acting+reversible+contraception+This+replaces+Chapter+7%3A+Progestogen-only+subdermal+implants+(POSDIs)+in+clinical+guideline+30&rlz=1C1EJFC_enIN814IN814&oq=Addendum+to+Clinical+Guideline+30%2C+Long-acting+reversible+contraception+This+replaces+Chapter+7%3A+Progestogen-only+subdermal+implants+(POSDIs)+in+clinical+guideline+30&aqs=chrome..69i57.647j0j7&sourceid=chrome&ie=UTF-8. UR - https://www.google.co.in/search?q=Addendum+to+Clinical+Guideline+30%2C+Long-acting+reversible+contraception+This+replaces+Chapter+7%3A+Progestogen-only+subdermal+implants+(POSDIs)+in+clinical+guideline+30&rlz=1C1EJFC_enIN814IN814&oq=Addendum+to+Clinical+Guideline+30%2C+Long-acting+reversible+contraception+This+replaces+Chapter+7%3A+Progestogen-only+subdermal+implants+(POSDIs)+in+clinical+guideline+30&aqs=chrome..69i57.647j0j7&sourceid=chrome&ie=UTF-8 ID - ref6 ER - TY - STD TI - Medical Eligibility Criteria for Implants | Family Planning [Internet]. [cited 2020 Nov 8]. https://www.fphandbook.org/medical-eligibility-criteria-implants. UR - https://www.fphandbook.org/medical-eligibility-criteria-implants ID - ref7 ER - TY - STD TI - National Collaborating Centre for Women’s and Children’s Health (UK). Long-acting Reversible Contraception: The Effective and Appropriate Use of Long-Acting Reversible Contraception [Internet]. London: RCOG Press; 2005 [cited 2018 Nov 6]. (National Institute for Health and Clinical Excellence: Guidance). http://www.ncbi.nlm.nih.gov/books/NBK51051/. UR - http://www.ncbi.nlm.nih.gov/books/NBK51051/ ID - ref8 ER - TY - STD TI - Contraceptive Failure Rates: new estimates from the 1995 National Survey of Family Growth [Internet]. Guttmacher Institute. 2005 [cited 2018 Nov 8]. https://www.guttmacher.org/journals/psrh/1999/03/contraceptive-failure-rates-new-estimates-1995-national-survey-family-growth. UR - https://www.guttmacher.org/journals/psrh/1999/03/contraceptive-failure-rates-new-estimates-1995-national-survey-family-growth ID - ref9 ER - TY - STD TI - Contraceptive Continuation rates—MEASURE Evaluation [Internet]. [cited 2020 Jun 27]. https://www.measureevaluation.org/prh/rh_indicators/family-planning/fp/continuation-rates. UR - https://www.measureevaluation.org/prh/rh_indicators/family-planning/fp/continuation-rates ID - ref10 ER - TY - JOUR AU - Halpern, V. AU - Raymond, E. G. AU - Lopez, L. M. PY - 2010 DA - 2010// TI - Repeated use of pre- and postcoital hormonal contraception for prevention of pregnancy JO - Cochrane Database Syst Rev. UR - https://doi.org/10.1002/14651858.CD007595 DO - 10.1002/14651858.CD007595 ID - Halpern2010 ER - TY - JOUR AU - Kendall, J. M. PY - 2003 DA - 2003// TI - Designing a research project: randomised controlled trials and their principles JO - Emerg Med J VL - 20 UR - https://doi.org/10.1136/emj.20.2.164 DO - 10.1136/emj.20.2.164 ID - Kendall2003 ER - TY - BOOK AU - Brown, S. AU - Eisenberg, L. PY - 1995 DA - 1995// TI - The best intentions: unintended pregnancy and the well-being of children and families PB - National Academy Press CY - Washington, DC ID - Brown1995 ER - TY - STD TI - ClinicalTrials.gov Background—ClinicalTrials.gov [Internet]. [cited 2020 Feb 19]. https://clinicaltrials.gov/ct2/about-site/background. UR - https://clinicaltrials.gov/ct2/about-site/background ID - ref14 ER - TY - STD TI - Clinical Trials Registry—India (CTRI) [Internet]. [cited 2020 Feb 19]. http://ctri.nic.in/Clinicaltrials/login.php. UR - http://ctri.nic.in/Clinicaltrials/login.php ID - ref15 ER - TY - STD TI - Clinical Trials Register [Internet]. [cited 2020 Feb 19]. https://www.clinicaltrialsregister.eu/ctr-search/search. UR - https://www.clinicaltrialsregister.eu/ctr-search/search ID - ref16 ER - TY - STD TI - ANZCTR [Internet]. [cited 2020 Feb 19]. https://www.anzctr.org.au/. UR - https://www.anzctr.org.au/ ID - ref17 ER - TY - STD TI - PRISMA [Internet]. [cited 2019 May 29]. http://prisma-statement.org/PRISMAStatement/FlowDiagram.aspx. UR - http://prisma-statement.org/PRISMAStatement/FlowDiagram.aspx ID - ref18 ER - TY - STD TI - Cochrane Risk of Bias Tool [Internet]. [cited 2019 Jan 8]. https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-019-1172-8. UR - https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-019-1172-8 ID - ref19 ER - TY - STD TI - ROBINS-I tool [Internet]. [cited 2020 Jun 27]. https://methods.cochrane.org/methods-cochrane/robins-i-tool. UR - https://methods.cochrane.org/methods-cochrane/robins-i-tool ID - ref20 ER - TY - STD TI - CASP-Cohort-Study-Checklist-2018_fillable_form.pdf [Internet]. [cited 2019 Jan 8]. https://casp-uk.net/wp-content/uploads/2018/03/CASP-Cohort-Study-Checklist-2018_fillable_form.pdf. UR - https://casp-uk.net/wp-content/uploads/2018/03/CASP-Cohort-Study-Checklist-2018_fillable_form.pdf ID - ref21 ER - TY - STD TI - Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS) | BMJ Open [Internet]. [cited 2020 Jun 27]. https://bmjopen.bmj.com/content/6/12/e011458. UR - https://bmjopen.bmj.com/content/6/12/e011458 ID - ref22 ER - TY - STD TI - Implanon: a review of the literature with recommendations for clinical management—PubMed [Internet]. [cited 2020 Jun 27]. https://pubmed.ncbi.nlm.nih.gov/19249660/. UR - https://pubmed.ncbi.nlm.nih.gov/19249660/ ID - ref23 ER - TY - STD TI - Phase-III Multicentre clinical trial with sub dermal single-rod contraceptive implant IMPLANON-R. An ICMR Task Force study. ID - ref24 ER - TY - JOUR AU - Flores, J. B. O. AU - Balderas, M. L. AU - Bonilla, M. C. AU - Vázquez-Estrada, L. PY - 2005 DA - 2005// TI - Clinical experience and acceptability of the etonogestrel subdermal contraceptive implant JO - Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet VL - 90 UR - https://doi.org/10.1016/j.ijgo.2005.06.007 DO - 10.1016/j.ijgo.2005.06.007 ID - Flores2005 ER - TY - JOUR AU - Agrawal, A. AU - Robinson, C. PY - 2005 DA - 2005// TI - An assessment of the first 3 years’ use of Implanon in Luton JO - J Fam Plann Reprod Health Care VL - 31 UR - https://doi.org/10.1783/147118905774480581 DO - 10.1783/147118905774480581 ID - Agrawal2005 ER - TY - JOUR AU - Aisien, A. O. AU - Enosolease, M. E. PY - 2010 DA - 2010// TI - Safety, efficacy and acceptability of implanon a single rod implantable contraceptive (etonogestrel) in University of Benin Teaching Hospital JO - Niger J Clin Pract VL - 13 ID - Aisien2010 ER - TY - JOUR AU - Arribas-Mir, L. AU - Rueda-Lozano, D. AU - Agrela-Cardona, M. AU - Cedeño-Benavides, T. AU - Olvera-Porcel, C. AU - Bueno-Cavanillas, A. PY - 2009 DA - 2009// TI - Insertion and 3-year follow-up experience of 372 etonogestrel subdermal contraceptive implants by family physicians in Granada JO - Spain Contraception VL - 80 UR - https://doi.org/10.1016/j.contraception.2009.04.003 DO - 10.1016/j.contraception.2009.04.003 ID - Arribas-Mir2009 ER - TY - JOUR AU - Gezginc, K. AU - Balci, O. AU - Karatayli, R. AU - Colakoglu, M. C. PY - 2007 DA - 2007// TI - Contraceptive efficacy and side effects of Implanon JO - Eur J Contracept Reprod Health Care Off J Eur Soc Contracept VL - 12 UR - https://doi.org/10.1080/13625180701548040 DO - 10.1080/13625180701548040 ID - Gezginc2007 ER - TY - JOUR AU - Gupta, S. AU - Mola, G. AU - Ramsay, P. AU - Jenkins, G. AU - Stein, W. AU - Bolnga, J. PY - 2017 DA - 2017// TI - Twelve month follow-up of a contraceptive implant outreach service in rural Papua New Guinea JO - Aust N Z J Obstet Gynaecol VL - 57 UR - https://doi.org/10.1111/ajo.12596 DO - 10.1111/ajo.12596 ID - Gupta2017 ER - TY - JOUR AU - Mutihir, J. T. AU - Daru, P. H. PY - 2008 DA - 2008// TI - Implanon sub-dermal implants: a 10-month review of acceptability in Jos, North-Central Nigeria JO - Niger J Clin Pract VL - 11 ID - Mutihir2008 ER - TY - JOUR AU - Smith, A. AU - Reuter, S. PY - 2002 DA - 2002// TI - An assessment of the use of Implanon in three community services JO - J Fam Plann Reprod Health Care VL - 28 UR - https://doi.org/10.1783/147118902101196540 DO - 10.1783/147118902101196540 ID - Smith2002 ER - TY - JOUR AU - Thamkhantho, M. AU - Jivasak-Apimas, S. AU - Angsuwathana, S. AU - Chiravacharadej, G. AU - Intawong, J. PY - 2008 DA - 2008// TI - One-year assessment of women receiving sub-dermal contraceptive implant at Siriraj Family Planning Clinic JO - J Med Assoc Thail Chotmaihet Thangphaet VL - 91 ID - Thamkhantho2008 ER - TY - JOUR AU - Winner, B. AU - Peipert, J. F. AU - Zhao, Q. AU - Buckel, C. AU - Madden, T. AU - Allsworth, J. E. PY - 2012 DA - 2012// TI - Effectiveness of long-acting reversible contraception JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1110855 DO - 10.1056/NEJMoa1110855 ID - Winner2012 ER - TY - JOUR AU - Apter, D. AU - Briggs, P. AU - Tuppurainen, M. AU - Grunert, J. AU - Lukkari-Lax, E. AU - Rybowski, S. PY - 2016 DA - 2016// TI - A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant JO - Fertil Steril VL - 106 UR - https://doi.org/10.1016/j.fertnstert.2016.02.036 DO - 10.1016/j.fertnstert.2016.02.036 ID - Apter2016 ER - TY - JOUR AU - Hubacher, D. AU - Spector, H. AU - Monteith, C. AU - Chen, P. -. L. AU - Hart, C. PY - 2017 DA - 2017// TI - Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial JO - Am J Obstet Gynecol VL - 216 UR - https://doi.org/10.1016/j.ajog.2016.08.033 DO - 10.1016/j.ajog.2016.08.033 ID - Hubacher2017 ER - TY - JOUR AU - Bahamondes, L. AU - Brache, V. AU - Meirik, O. AU - Ali, M. AU - Habib, N. AU - Landoulsi, S. PY - 2015 DA - 2015// TI - A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls JO - Hum Reprod Oxf Engl VL - 30 UR - https://doi.org/10.1093/humrep/dev221 DO - 10.1093/humrep/dev221 ID - Bahamondes2015 ER - TY - JOUR AU - Berenson, A. B. AU - Tan, A. AU - Hirth, J. M. PY - 2015 DA - 2015// TI - Complications and continuation rates associated with 2 types of long-acting contraception JO - Am J Obstet Gynecol VL - 212 UR - https://doi.org/10.1016/j.ajog.2014.12.028 DO - 10.1016/j.ajog.2014.12.028 ID - Berenson2015 ER - TY - JOUR AU - Birgisson, N. E. AU - Zhao, Q. AU - Secura, G. M. AU - Madden, T. AU - Peipert, J. F. PY - 2015 DA - 2015// TI - Preventing unintended pregnancy: the contraceptive CHOICE Project in review JO - J Womens Health 2002. VL - 24 ID - Birgisson2015 ER - TY - JOUR AU - Yildizbas, B. AU - Sahin, H. G. AU - Kolusari, A. AU - Zeteroglu, S. AU - Kamaci, M. PY - 2007 DA - 2007// TI - Side effects and acceptability of Implanon: a pilot study conducted in eastern Turkey JO - Eur J Contracept Reprod Health Care Off J Eur Soc Contracept VL - 12 UR - https://doi.org/10.1080/13625180701442228 DO - 10.1080/13625180701442228 ID - Yildizbas2007 ER - TY - STD TI - Bitzer J, Tschudin S, Alder J, Swiss Implanon Study Group. Acceptability and side-effects of Implanon in Switzerland: a retrospective study by the Implanon Swiss Study Group. Eur J Contracept Reprod Health Care Off J Eur Soc Contracept. 2004;9(4):278–84. ID - ref41 ER - TY - JOUR AU - Casey, S. E. AU - Cannon, A. AU - Mushagalusa Balikubirhi, B. AU - Muyisa, J. -. B. AU - Amsalu, R. AU - Tsolka, M. PY - 2017 DA - 2017// TI - Twelve-month contraceptive continuation among women initiating short- and long-acting reversible contraceptives in North Kivu, Democratic Republic of the Congo JO - PLoS ONE VL - 12 UR - https://doi.org/10.1371/journal.pone.0182744 DO - 10.1371/journal.pone.0182744 ID - Casey2017 ER - TY - JOUR AU - Romano, M. E. AU - Braun-Courville, D. K. PY - 2019 DA - 2019// TI - Assessing weight status in adolescent and young adult users of the etonogestrel contraceptive implant JO - J Pediatr Adolesc Gynecol VL - 32 UR - https://doi.org/10.1016/j.jpag.2019.03.008 DO - 10.1016/j.jpag.2019.03.008 ID - Romano2019 ER - TY - JOUR AU - Modesto, W. AU - Ava, N. AU - Monteiro, I. AU - Bahamondes, L. PY - 2015 DA - 2015// TI - Body composition and bone mineral density in users of the etonogestrel-releasing contraceptive implant JO - Arch Gynecol Obstet VL - 292 UR - https://doi.org/10.1007/s00404-015-3784-0 DO - 10.1007/s00404-015-3784-0 ID - Modesto2015 ER - TY - JOUR AU - Vickery, Z. AU - Madden, T. AU - Zhao, Q. AU - Secura, G. M. AU - Allsworth, J. E. AU - Peipert, J. F. PY - 2013 DA - 2013// TI - Weight change at 12 months in users of three progestin-only contraceptive methods JO - Contraception VL - 88 UR - https://doi.org/10.1016/j.contraception.2013.03.004 DO - 10.1016/j.contraception.2013.03.004 ID - Vickery2013 ER - TY - JOUR AU - Guazzelli, C. A. F. AU - Queiroz, F. T. AU - Barbieri, M. AU - Barreiros, F. A. AU - Torloni, M. R. AU - Araujo, F. F. PY - 2011 DA - 2011// TI - Metabolic effects of contraceptive implants in adolescents JO - Contraception VL - 84 UR - https://doi.org/10.1016/j.contraception.2011.02.006 DO - 10.1016/j.contraception.2011.02.006 ID - Guazzelli2011 ER - TY - JOUR AU - Villas-Boas, J. AU - Vilodre, L. C. AU - Malerba, H. AU - Pontremoli Salcedo, M. AU - Foresti Jiménez, M. AU - Beitune, P. PY - 2016 DA - 2016// TI - Metabolic safety of the etonogestrel contraceptive implant in healthy women over a 3-year period JO - Eur J Obstet Gynecol Reprod Biol VL - 202 UR - https://doi.org/10.1016/j.ejogrb.2016.04.025 DO - 10.1016/j.ejogrb.2016.04.025 ID - Villas-Boas2016 ER - TY - JOUR AU - Oderich, C. L. AU - Wender, M. C. O. AU - Lubianca, J. N. AU - Santos, L. M. AU - Mello, G. C. PY - 2012 DA - 2012// TI - Impact of etonogestrel-releasing implant and copper intrauterine device on carbohydrate metabolism: a comparative study JO - Contraception VL - 85 UR - https://doi.org/10.1016/j.contraception.2011.05.018 DO - 10.1016/j.contraception.2011.05.018 ID - Oderich2012 ER - TY - JOUR AU - Mørch, L. S. AU - Skovlund, C. W. AU - Hannaford, P. C. AU - Iversen, L. AU - Fielding, S. AU - Lidegaard, Ø. PY - 2017 DA - 2017// TI - Contemporary hormonal contraception and the risk of breast cancer JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMoa1700732 DO - 10.1056/NEJMoa1700732 ID - Mørch2017 ER - TY - JOUR AU - Iversen, L. AU - Fielding, S. AU - Lidegaard, Ø. AU - Mørch, L. S. AU - Skovlund, C. W. AU - Hannaford, P. C. PY - 2018 DA - 2018// TI - Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study JO - BMJ VL - 26 UR - https://doi.org/10.1136/bmj.k3609 DO - 10.1136/bmj.k3609 ID - Iversen2018 ER - TY - JOUR AU - Lidegaard, Ø. AU - Løkkegaard, E. AU - Jensen, A. AU - Skovlund, C. W. AU - Keiding, N. PY - 2012 DA - 2012// TI - Thrombotic stroke and myocardial infarction with hormonal contraception JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1111840 DO - 10.1056/NEJMoa1111840 ID - Lidegaard2012 ER - TY - JOUR AU - Hidalgo, M. M. AU - Lisondo, C. AU - Juliato, C. T. AU - Espejo-Arce, X. AU - Monteiro, I. AU - Bahamondes, L. PY - 2006 DA - 2006// TI - Ovarian cysts in users of Implanon and Jadelle subdermal contraceptive implants JO - Contraception VL - 73 UR - https://doi.org/10.1016/j.contraception.2005.12.012 DO - 10.1016/j.contraception.2005.12.012 ID - Hidalgo2006 ER - TY - JOUR AU - Abraham, M. AU - Zhao, Q. AU - Peipert, J. F. PY - 2015 DA - 2015// TI - Young age, nulliparity, and continuation of long-acting reversible contraceptive methods JO - Obstet Gynecol VL - 126 UR - https://doi.org/10.1097/AOG.0000000000001036 DO - 10.1097/AOG.0000000000001036 ID - Abraham2015 ER - TY - JOUR AU - Agostini, A. AU - Godard, C. AU - Laurendeau, C. AU - Benmahmoud Zoubir, A. AU - Lafuma, A. AU - Lévy-Bachelot, L. PY - 2018 DA - 2018// TI - Two year continuation rates of contraceptive methods in France: a cohort study from the French national health insurance database JO - Eur J Contracept Reprod Health Care Off J Eur Soc Contracept VL - 23 UR - https://doi.org/10.1080/13625187.2018.1535653 DO - 10.1080/13625187.2018.1535653 ID - Agostini2018 ER - TY - JOUR AU - Berlan, E. AU - Mizraji, K. AU - Bonny, A. E. PY - 2016 DA - 2016// TI - Twelve-month discontinuation of etonogestrel implant in an outpatient pediatric setting JO - Contraception VL - 94 UR - https://doi.org/10.1016/j.contraception.2016.02.030 DO - 10.1016/j.contraception.2016.02.030 ID - Berlan2016 ER - TY - JOUR AU - Cea Soriano, L. AU - Wallander, M. -. A. AU - Andersson, S. AU - Filonenko, A. AU - García Rodríguez, L. A. PY - 2015 DA - 2015// TI - The continuation rates of long-acting reversible contraceptives in UK general practice using data from The Health Improvement Network JO - Pharmacoepidemiol Drug Saf VL - 24 UR - https://doi.org/10.1002/pds.3710 DO - 10.1002/pds.3710 ID - Cea Soriano2015 ER - TY - JOUR AU - Chiles, D. P. AU - Roberts, T. A. AU - Klein, D. A. PY - 2016 DA - 2016// TI - Initiation and continuation of long-acting reversible contraception in the United States military healthcare system JO - Am J Obstet Gynecol VL - 215 UR - https://doi.org/10.1016/j.ajog.2016.03.027 DO - 10.1016/j.ajog.2016.03.027 ID - Chiles2016 ER - TY - JOUR AU - Griffiths, E. K. AU - Marley, J. V. AU - Friello, D. AU - Atkinson, D. N. PY - 2016 DA - 2016// TI - Uptake of long-acting, reversible contraception in three remote Aboriginal communities: a population-based study JO - Med J Aust VL - 205 UR - https://doi.org/10.5694/mja16.00073 DO - 10.5694/mja16.00073 ID - Griffiths2016 ER - TY - JOUR AU - Grunloh, D. S. AU - Casner, T. AU - Secura, G. M. AU - Peipert, J. F. AU - Madden, T. PY - 2013 DA - 2013// TI - Characteristics associated with discontinuation of long-acting reversible contraception within the first 6 months of use JO - Obstet Gynecol VL - 122 UR - https://doi.org/10.1097/01.AOG.0000435452.86108.59 DO - 10.1097/01.AOG.0000435452.86108.59 ID - Grunloh2013 ER - TY - JOUR AU - Harvey, C. AU - Seib, C. AU - Lucke, J. PY - 2009 DA - 2009// TI - Continuation rates and reasons for removal among Implanon users accessing two family planning clinics in Queensland, Australia JO - Contraception VL - 80 UR - https://doi.org/10.1016/j.contraception.2009.05.132 DO - 10.1016/j.contraception.2009.05.132 ID - Harvey2009 ER - TY - JOUR AU - Howard, D. L. AU - Ford, A. AU - Ceballos, S. AU - Volker, K. W. PY - 2018 DA - 2018// TI - Temporal trends in the uptake and continuation of the etonogestrel implant in a large private practice setting JO - J Womens Health 2002. VL - 27 ID - Howard2018 ER - TY - JOUR AU - Lakha, F. AU - Glasier, A. F. PY - 2006 DA - 2006// TI - Continuation rates of Implanon in the UK: data from an observational study in a clinical setting JO - Contraception VL - 74 UR - https://doi.org/10.1016/j.contraception.2006.05.072 DO - 10.1016/j.contraception.2006.05.072 ID - Lakha2006 ER - TY - JOUR AU - Peipert, J. F. AU - Zhao, Q. AU - Allsworth, J. E. AU - Petrosky, E. AU - Madden, T. AU - Eisenberg, D. PY - 2011 DA - 2011// TI - Continuation and satisfaction of reversible contraception JO - Obstet Gynecol VL - 117 UR - https://doi.org/10.1097/AOG.0b013e31821188ad DO - 10.1097/AOG.0b013e31821188ad ID - Peipert2011 ER - TY - JOUR AU - Peterson, A. M. AU - Brown, A. AU - Savage, A. AU - Dempsey, A. PY - 2019 DA - 2019// TI - Prevalence of early discontinuation and associated factors among a retrospective cohort of etonogestrel contraceptive implant users JO - Eur J Contracept Reprod Health Care Off J Eur Soc Contracept VL - 24 UR - https://doi.org/10.1080/13625187.2019.1666361 DO - 10.1080/13625187.2019.1666361 ID - Peterson2019 ER - TY - JOUR AU - Rominski, S. D. AU - Manu, A. AU - Maya, E. AU - Morhe, E. S. K. AU - Dalton, V. K. PY - 2018 DA - 2018// TI - Discontinuation of long-acting reversible contraception versus short-term hormonal methods in urban Ghana: a pilot longitudinal study JO - Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet VL - 142 UR - https://doi.org/10.1002/ijgo.12518 DO - 10.1002/ijgo.12518 ID - Rominski2018 ER - TY - JOUR AU - Sanders, J. N. AU - Turok, D. K. AU - Gawron, L. M. AU - Law, A. AU - Wen, L. AU - Lynen, R. PY - 2017 DA - 2017// TI - Two-year continuation of intrauterine devices and contraceptive implants in a mixed-payer setting: a retrospective review JO - Am J Obstet Gynecol VL - 216 UR - https://doi.org/10.1016/j.ajog.2017.02.003 DO - 10.1016/j.ajog.2017.02.003 ID - Sanders2017 ER - TY - JOUR AU - Short, M. AU - Dallay, D. AU - Omokanye, S. AU - Hanisch, J. U. AU - Inki, P. PY - 2012 DA - 2012// TI - Acceptability of the levonorgestrel releasing-intrauterine system and etonogestrel implant: one-year results of an observational study JO - Eur J Contracept Reprod Health Care Off J Eur Soc Contracept VL - 17 UR - https://doi.org/10.3109/13625187.2011.636088 DO - 10.3109/13625187.2011.636088 ID - Short2012 ER - TY - JOUR AU - Sznajder, K. K. AU - Tomaszewski, K. S. AU - Burke, A. E. AU - Trent, M. PY - 2017 DA - 2017// TI - Incidence of discontinuation of long-acting reversible contraception among adolescent and young adult women served by an urban primary care clinic JO - J Pediatr Adolesc Gynecol VL - 30 UR - https://doi.org/10.1016/j.jpag.2016.06.012 DO - 10.1016/j.jpag.2016.06.012 ID - Sznajder2017 ER - TY - JOUR AU - Teunissen, A. M. AU - Grimm, B. AU - Roumen, F. J. M. E. PY - 2014 DA - 2014// TI - Continuation rates of the subdermal contraceptive Implanon(®) and associated influencing factors JO - Eur J Contracept Reprod Health Care Off J Eur Soc Contracept VL - 19 UR - https://doi.org/10.3109/13625187.2013.862231 DO - 10.3109/13625187.2013.862231 ID - Teunissen2014 ER - TY - JOUR AU - Weisberg, E. AU - Bateson, D. AU - McGeechan, K. AU - Mohapatra, L. PY - 2014 DA - 2014// TI - A three-year comparative study of continuation rates, bleeding patterns and satisfaction in Australian women using a subdermal contraceptive implant or progestogen releasing-intrauterine system JO - Eur J Contracept Reprod Health Care Off J Eur Soc Contracept VL - 19 UR - https://doi.org/10.3109/13625187.2013.853034 DO - 10.3109/13625187.2013.853034 ID - Weisberg2014 ER - TY - STD TI - Early Implanon discontinuation rate and its associated factors in health institutions of Mekelle City, Tigray, Ethiopia 2016/17 [Internet]. [cited 2020 Feb 19]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323816/. UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323816/ ID - ref71 ER - TY - JOUR AU - O’neil-Callahan, M. AU - Peipert, J. F. AU - Zhao, Q. AU - Madden, T. AU - Secura, G. PY - 2013 DA - 2013// TI - Twenty-four-month continuation of reversible contraception JO - Obstet Gynecol. VL - 122 UR - https://doi.org/10.1097/AOG.0b013e3182a91f45 DO - 10.1097/AOG.0b013e3182a91f45 ID - O’neil-Callahan2013 ER - TY - STD TI - Discontinuation rate of Implanon and its associated factors among women who ever used Implanon in Dale District, Southern Ethiopia [Internet]. [cited 2020 Feb 19]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245529/. UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245529/ ID - ref73 ER - TY - JOUR AU - Casey, P. M. AU - Long, M. E. AU - Marnach, M. L. AU - Bury, J. E. PY - 2011 DA - 2011// TI - Bleeding related to etonogestrel subdermal implant in a US population JO - Contraception VL - 83 UR - https://doi.org/10.1016/j.contraception.2010.09.012 DO - 10.1016/j.contraception.2010.09.012 ID - Casey2011 ER - TY - STD TI - Heterogeneity in Meta-analysis (Q, I-square)—StatsDirect [Internet]. [cited 2020 Nov 8]. https://www.statsdirect.com/help/meta_analysis/heterogeneity.htm. UR - https://www.statsdirect.com/help/meta_analysis/heterogeneity.htm ID - ref75 ER - TY - STD TI - Smith K, Nayyar S, Rana T, Archibong AE, Looney KR, Nayyar T. Do progestin-only contraceptives contribute to the risk of developing depression as implied by beta-arrestin 1 levels in leukocytes? A pilot study. Int J Environ Res Public Health [Internet]. 2018 Sep [cited 2020 May 21];15(9). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163405/. UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163405/ ID - ref76 ER - TY - STD TI - Power J, French R, Cowan F. Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy. Cochrane Database Syst Rev. 2007;(3):CD001326. ID - ref77 ER - TY - STD TI - Lopez LM, Grimes DA, Schulz KF, Curtis KM, Chen M. Steroidal contraceptives: effect on bone fractures in women. Cochrane Database Syst Rev [Internet]. 2014 [cited 2020 Jun 5]. https://doi.org/10.1002/14651858.CD006033.pub5/full?cookiesEnabled. ID - ref78 ER - TY - STD TI - Lopez LM, Bernholc A, Chen M, Grey TW, Otterness C, Westhoff C, et al. Hormonal contraceptives for contraception in overweight or obese women. Cochrane Database Syst Rev. 2016;(8):CD008452. ID - ref79 ER - TY - JOUR AU - Diedrich, J. T. AU - Klein, D. A. AU - Peipert, J. F. PY - 2017 DA - 2017// TI - Long-acting reversible contraception in adolescents: a systematic review and meta-analysis JO - Am J Obstet Gynecol VL - 216 UR - https://doi.org/10.1016/j.ajog.2016.12.024 DO - 10.1016/j.ajog.2016.12.024 ID - Diedrich2017 ER - TY - STD TI - Paynter M. Nexplanon, a 3-year birth control implant, is now approved for use in Canada [Internet]. The Conversation. [cited 2020 Jul 20]. http://theconversation.com/nexplanon-a-3-year-birth-control-implant-is-now-approved-for-use-in-canada-139658. UR - http://theconversation.com/nexplanon-a-3-year-birth-control-implant-is-now-approved-for-use-in-canada-139658 ID - ref81 ER - TY - STD TI - Akilimali PZ, J H, P A, K P K, J B. . Incidence and determinants of Implanon discontinuation: findings from a prospective cohort study in three health zones in Kinshasa, DRC. PLoS One. 2020;15(5):e0232582. https://doi.org/10.1371/journal.pone.0232582. ID - ref82 ER - TY - STD TI - Chapter 4: Searching for and selecting studies [Internet]. [cited 2020 Dec 1]. https://training.cochrane.org/handbook/current/chapter-04. UR - https://training.cochrane.org/handbook/current/chapter-04 ID - ref83 ER -